List of Schedule III drugs (US)

From Wikipedia, the free encyclopedia
Jump to: navigation, search

This is the list of Schedule III drugs as defined by the United States Controlled Substances Act.[1] The following findings are required for drugs to be placed in this schedule:[2]

  1. The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II.
  2. The drug or other substance has a currently accepted medical use in treatment in the United States.
  3. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.

The complete list of Schedule III drugs follows.[1] The Administrative Controlled Substances Code Number for each drug is included.

Stimulants[edit]

ACSCN Drug
1405 See 21 CFR 1308.13(b)(1)
1228 Benzphetamine
1645 Chlorphentermine
1647 Clortermine
1615 Phendimetrazine

Depressants[edit]

ACSCN Drug
2126 Amobarbital
2100 Any derivative of Barbituric acid
2510 Chlorhexadol
2020 Embutramide
2012 Xyrem (sodium oxybate) oral solution[3]
2261 Perampanel[4]
7285 Ketamine
2575 Methyprylon
2600 Sulfondiethylmethane
2605 Sulfonethylmethane
2610 Sulfonmethane
7295 Tiletamine and zolazepam
7369 Dronabinol in sesame oil and encapsulated in a soft gelatin capsule

Others[edit]

ACSCN Drug
9400 Nalorphine

Narcotics[edit]

ACSCN Drug
9803 Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium
9804 Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
9805 Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium
9806 Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts
9807 Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts
9808 Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
9809 Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
9810 Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
9064 Buprenorphine

Steroids[edit]

ACSCN Drug
4000 Anabolic steroids

Hallucinogens[edit]

ACSCN Drug
7300 Lysergic acid
7310 Lysergic acid amide

References[edit]

  1. ^ a b 21 CFR 1308.13 (CSA Sched III) with changes through 77 F.R. 64032 (Oct 18, 2012). Retrieved September 6, 2013.
  2. ^ 21 U.S.C. § 812(b)(3) retrieved October 2, 2007
  3. ^ "Xyrem® (sodium oxybate) Oral Solution CIII. Prescribing information. Revised: December 2012". 
  4. ^ "Department of Justice. Drug Enforcement Administration. Schedules of Controlled Substances: Placement of Perampanel into Schedule III". Federal Register (Office of the Federal Register, National Archives and Records Administration) 78 (204): 62500–62506. October 22, 2013. Retrieved 22 February 2014.